Scott Webster
therapeutic areas
Caprion Proteomics
Australia
Biography
Prof Webster has over 17 years experience in drug discovery in industry and academia effectively translating research across therapeutic areas and disciplines. He has a successful track record in medicines discovery, leading programmes through preclinical discovery, clinical development and licensing. His successes include the discovery and development of Xanamem and other compounds currently in development for acute pancreatitis and multiple organ failure. He has considerable experience of initiating and leading multiple research projects and of working collaboratively with pharmaceutical industry partners.
Research Interest
Prof Webster has over 17 years experience in drug discovery in industry and academia effectively translating research across therapeutic areas and disciplines. He has a successful track record in medicines discovery, leading programmes through preclinical discovery, clinical development and licensing. His successes include the discovery and development of Xanamem and other compounds currently in development for acute pancreatitis and multiple organ failure. He has considerable experience of initiating and leading multiple research projects and of working collaboratively with pharmaceutical industry partners.
